Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor
Neurofibromatosis type 1 (NF1) is one of the most common tumor-predisposing genetic disorders. Neurofibromas are NF1-associated benign tumors. A hallmark feature of neurofibromas is an abundant collagen-rich extracellular matrix (ECM) that constitutes more than 50% of the tumor dry weight. However,...
Main Authors: | Chunhui Jiang, Ashwani Kumar, Ze Yu, Tracey Shipman, Yong Wang, Renee M. McKay, Chao Xing, Lu Q. Le |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-06-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI168227 |
Similar Items
-
Targeting the extracellular matrix for NF1-associated neurofibroma treatment
by: Chunhui Jiang
Published: (2024-06-01) -
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
by: Leah J. Kershner, et al.
Published: (2022-09-01) -
Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective Study
by: Antonella Cacchione MD, et al.
Published: (2023-01-01) -
Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas
by: Amy E. Armstrong, et al.
Published: (2023-06-01) -
Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs
by: Bih-Rong Wei, et al.
Published: (2022-12-01)